Qube Research & Technologies Ltd

Position in ARDX — Ardelyx, Inc.

CIK 1729829 LONDON, X0

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,662,442

-$3,926,490 QoQ

Shares Held

2,090,675

-14.2% QoQ

Ownership

0.839%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#20

of 250 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. ARDX ranks #45 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,662,442	2,090,675	-14.2%	Shares	Sole	2026-08-14
2026-03-31	$14,588,932	2,435,548	+122.2%	Shares	Sole	2026-05-15
2025-12-31	$6,390,362	1,096,117	+1681.5%	Shares	Sole	2026-02-17
2024-12-31	$311,946	61,528	+298.1%	Shares	Sole	2025-02-14
2024-09-30	$106,491	15,456	-88.4%	Shares	Sole	2024-11-14
2023-06-30	$450,951	133,024	+220.2%	Shares	Sole	2023-08-14
2023-03-31	$198,971	41,539	-44.9%	Shares	Sole	2023-05-15
2022-09-30	$89,746	75,417	-24.3%	Shares	Sole	2022-11-14
2022-06-30	$58,764	99,600	-45.2%	Shares	Sole	2022-08-15
2021-12-31	$199,811	181,647	+591.7%	Shares	Sole	2022-02-10
2020-09-30	$137,875	26,262	+122.1%	Shares	Sole	2020-11-12
2020-03-31	$67,225	11,825	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.